Core Viewpoint - The company has successfully launched a new product, the recombinant protein-based oral repair toothpaste, which has shown strong sales performance since its introduction [1][2]. Group 1: Product Performance - The new recombinant protein-based oral repair toothpaste integrates patented ingredients, achieving a dual repair function for gums [1]. - Sales on the Douyin platform have reached between 25 million to 50 million [1]. Group 2: Financial Performance - In Q3 2025, the company reported revenue of 386 million, a year-on-year increase of 10.49%, and a net profit attributable to shareholders of 51 million, up 11.4% [2]. - The gross margin for Q3 2025 was 45.9%, reflecting an 8 percentage point decrease, attributed to a reduction in high-margin product sales [2]. - The sales expense ratio was 25.5%, down 8 percentage points, indicating effective management of online advertising expenditures [2]. Group 3: Investment Outlook - The company is expected to maintain stable growth, with the new toothpaste potentially replicating the success of previous high-performance products [3]. - Forecasted net profits for 2025 and 2026 are 190 million and 240 million, respectively, with corresponding price-to-earnings ratios of 34x and 27x [3].

Core Viewpoint - In Q2 2025, the company achieved a revenue growth of 20.1% year-on-year and a net profit growth of 19.7%, driven by the increasing proportion of high-margin medical research products [1][3] - The adult toothpaste segment led the growth in H1 2025, with a focus on the "Medical Research 7-Day Repair Toothpaste" and a significant online sales presence, particularly on Douyin [1][4] - E-commerce sales surged by 81.13% year-on-year, accounting for 38.62% of total revenue, while offline channel revenue remained stable [1][5] Financial Performance - For H1 2025, the company reported a revenue of 842 million yuan, up 19.7%, and a net profit of 85 million yuan, up 17.6%, with a basic EPS of 0.49 yuan [2] - In Q2 2025, revenue reached 411 million yuan, reflecting a 20.1% increase, and net profit was 42 million yuan, up 19.7% [3] Product Performance - Adult toothpaste revenue in H1 2025 was 677 million yuan, growing by 23%, with a gross margin of 53.59% [4] - New product launches in the adult toothpaste category included high-end variants, contributing to a significant increase in the share of mid-to-high-end products [4] - Emerging categories such as electric toothbrushes and oral healthcare products saw substantial growth, with electric toothbrush revenue increasing by 37.33% [4] Channel Performance - E-commerce and other channels generated 325 million yuan in H1 2025, marking an 81.13% increase, while offline channel revenue was stable at 516 million yuan [5] - The company leveraged Douyin to expand online presence, which positively impacted offline sales as well [5] Cost and Profitability - The gross margin for H1 2025 was 52.61%, up 5.68 percentage points, primarily due to the higher revenue share from high-margin products [6] - The net profit margin for H1 2025 was 10.12%, indicating stable profitability despite increased marketing expenses [7] Future Outlook - Revenue projections for 2023-2025 are 1.89 billion, 2.27 billion, and 2.69 billion yuan, with expected growth rates of 21.0%, 20.3%, and 18.3% respectively [7] - The company anticipates continued growth in net profit, with estimates of 203 million, 255 million, and 308 million yuan for the same period [7]